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Introduction 
Primary graft dysfunction (PGD) is a syndrome related to 
allograft ischemia-reperfusion injury that occurs within the 
first 72 hours after lung transplantation. In the early days 
of lung transplantation, the incidence of PGD is difficult 
to assess accurately, with a reported range varying from 
15% to 57%, partly as a result of differing definitions (1,2). 
The diagnosis is based on the presence of diffuse alveolar 
infiltrates on chest radiography without other identifiable 
causes and graduated on PaO2 fraction of inspired oxygen 
(FiO2) value (3,4). Notably, PGD is a risk factor for early 
and 1-year mortality; in addition, PGD is related to the 
development of bronchiolitis obliterans syndrome (5). 
Conversely, its role in association with functional 
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outcomes is less clear (3,6) and the evolution of tissue 
damaged from the ischemia-reperfusion injury has only 
sporadically been studied (7). In this scenario, functional 
analysis of multi-volumetric computed tomography (CT) 
represents an attractive tool that offers the possibility to 
study and understand the ‘parenchymal outcome’ after 
lung transplantation, opening the door to patient-tailored 
management (8).
The overall purpose of this pilot study was to determine 
whether development of PGD in the first 72 hours after 
lung transplantation influences parenchymal remodeling 
quantitatively assessed by CT at 3- and 12-month follow-up.
Methods
Study design
We designed a prospective, observational, single blind pilot 
study, based on dedicated institutional database. The study 
was performed in compliance with the principles of the 
declaration of Helsinki and received the approval of the 
local ethics committee (749_2016bis). All participants gave 
written informed consent before they were included in the 
study.
Patient population
We prospectively enrolled all patients who underwent 
bilateral lung transplantation at Fondazione IRCCS Ca’ 
Granda-Ospedale Maggiore Policlinico of Milan between 
June 2013 and February 2017. Exclusion criteria were age 
<18 years and consent denied. 
PGD diagnosis and grading 
Patients were evaluated at 24, 48 and 72 hours after the end 
of surgery to establish PGD occurrence and grading. Two 
Authors (M Nosotti, A Palleschi) examined independently 
the chest X-ray. According to the standard ISHLT criteria, 
given the multi-factorial and likely additive nature of 
PGD risk factors, if parenchymal infiltrates were present, 
every other possibility was investigated and excluded (4). 
If any discrepancy occurred between the researchers, they 
proceeded to a collegial review of clinical and radiological 
parameters. PGD was graded on the basis of PaO2/FiO2 
ratio and recorded on the database. Patients were classified 
in two groups according the worst PGD within the first 
72 hours. Patients without evidence of PGD constituted 
the PGD0 Group; patients with grade 2 and/or 3 graft 
dysfunction within first 72 hours after lung transplantation 
composed the PGD Group. 
Surveillance protocol 
Besides fifteen-day medical examination, our standard 
surveillance protocol included pulmonary function tests 
(PFTs), multi-volumetric CT scans, and bronchoscopy with 
trans-bronchial biopsy at 3, 6 and 12 months. All data of 
interest were recorded in the dedicated database.
Specifically, PFT consists in a spirometry (Spirolab, 
Medical International Research, Italy) performed on the 
same day of the CT scan. This test included the measure 
of forced-expiratory volume in 1 second (FEV1) and forced 
vital capacity (FVC); the values were expressed also as 
percentage of predicted (FEV1%, FVC %).
Patients underwent low dose, non-contrast CT scan with 
BrightSpeed™ Elite SD (GE Healthcare, CT, USA). CT 
images were acquired during breath holding at full end-
inspiration (INSP) and full end-expiration (EXP) with the 
following parameters: tube voltage, 100 kVp, reference tube 
current, 245 mAs, pitch factor, 1.75, image matrix, 512×512, 
slice thickness 2.5 mm, with a smooth filter (B30). The DLP 
(Dose Length Product) was in the range between 110 and 
328 mGy/cm, and the CTDIVol (Computed Tomography 
Dose Index Vol) was in the range between 1.8 and 4.9 mGy 
which is a low radiation dose compared to the doses used for 
routine chest scanning in many institutions (9).
Quantitative image analysis 
For the aim of the study, we considered the surveillance CT 
scans at 3 and 12 months (±10 days) after transplantation. 
Image analysis was performed, in terms of specific gas 
volume (SVg) for the entire lung. SVg is defined as the 
difference between specific volume of tissue and gas and the 
specific volume of tissue, expressed in mL (gas)/g (tissue) 
(10-13). For the calculation of SVg, voxels belonging to 
airways, blood vessels, and other structures of the lung were 
excluded and only those belonging to the parenchyma, i.e., 
with Hounsfield Unit values <−600 HU, were considered. 
Changes of SVg (ΔSVg = SVgINSP − SVgEXP, expressed as 
mL·g−1, where SVgINSP and SVgEXP are specific gas volume 
at EXP and INSP, respectively) normalized on SVgEXP were 
calculated as ΔSVg/SVgEXP. Additional measures included 
CT total lung volumes (VEXP and VINSP) at each time point, 
as described elsewhere (9,10,12).
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CT functional mask
In order to identify ventilation defects on a pixel-by-pixel 
basis, individual maps of CT density change between the 
two lung volumes (ΔHU = HUEXP − HUINSP) were obtained 
on five different lung levels, from the aortic arch to the 
top of the diaphragm. Firstly, INSP and EXP images were 
semi-automatically segmented to separate lung parenchyma 
from the surrounding tissues. Successively, expiratory 
images were automatically deformed to the corresponding 
inspiratory images by using the Lucas-Kanade optical-
flow algorithm (14,15) and then subtracted pixel-by-pixel, 
providing maps of ΔHU (10). Each pixel was then classified 
as belonging to four different possible functional settings: 
(I) low ventilated (green), (II) consolidation (blue), (III) air 
trapping (red) and (IV) healthy regions (black).
The change in density was calculated for each voxel of 
the ΔHU map and the classification was determined by 
imposing four thresholds: (I) the threshold for healthy 
regions (H, in black) was determined by considering a 
variation greater or equal to 100 (16); (II) pixels with values 
less than −950 HU on inspiration (HUINSP <−950 HU) and 
less than −856 HU on expiration images (HUEXP <−856) in 
conjunction with ΔHU <100 denoted air trapping (AT, in 
red) (8); (III) ΔHU <100, in conjunction with either HUEXP 
>−856 or HUINSP >−950 HU designated low ventilated 
regions (LV, in green) and (IV) ΔHU <100, in conjunction 
with HUEXP and HUINSP >−400 HU denoted the areas of 
abnormally high attenuation (C, in blue).
The percentages of LV, C, AT and H regions with 
respect to total area in the analyzed slices, denoted as %LV, 
%C, %AT and %H, respectively were calculated across the 
five ΔHU maps. 
All algorithms for image processing and quantitative 
analysis were implemented by custom software developed in 
MATLAB (The MathWorksInc, Natick, MA).
Statistical analysis 
Statistical analysis was performed using SigmaStat version 
12.5 (Systat Software, San Jose, CA, USA). Bivariate 
analyses were conducted using Mann Whitney’s U-test for 
continuous variables and chi-square or Fisher’s exact tests 
for categorical variables. Paired t-test was used to assess 
differences between time points and groups. A one-tailed 
paired t-test was performed to analyze the extent of change 
in ΔSVg/SVgEXP and %LV between groups. Regression 
analyses were performed to correlate the relative change 
in VEXP/VINSP and ΔSVg/SVgEXP and %LV. A P<0.05 was 
considered statistically significant.
Results
The study population is shown in Figure 1. Namely, 38 
subjects were included in this study; there were 13 males 
and 25 females, with a median age of 38 years. The 
characteristics of the patients are summarized in Table 1. 
Functional outcomes 
Three months after lung transplantation, PFTs showed that 
patients with or without PGD had statistically different 
reached values (FEV1% 64±13 vs. 79±19, P=0.014; FVC% 
65±11 vs. 77±16, P=0.032); conversely, comparable 
results were obtained at 12 months (FEV1% 82±19 vs. 
90±22; FVC% 81±15 vs. 91±21). The analysis of paired 
data revealed a significant growth in FEV1% and FVC% 
(P<0.001) in both PGD group after 12 months.
Functional CT parameters 
The distribution of ΔSVg/SVgEXP at study time-points is 
shown in Figure 2. At 3 months, ΔSVg/SVgEXP showed no 
significant differences among groups. At 12 months, ΔSVg/
SVgEXP increased significantly in both groups, in PGD 
passing from 0.67±0.38 to 1.02±0.50 (P=0.028) and in 
PGD0 patients from 0.72±0.39 to 1.20±0.49 (P<0.001). 
Results from functional mask analysis are reported in 
Figure 3. The distribution of %LV, %H %C, and %AT at 
3 and 12 months post transplantation in PGD and PGD0 
groups are showed. 
The analysis for paired data revealed that there was 
a significant decrease in LV% in both PGD group after 
12 months (P<0.05 and P<0.01, respectively) and a 
correspondent significant increase in H% (P<0.05 and 
P<0.01, respectively). %C and %AT were negligible in both 
transplanted groups at 3 and 12 months.
Figure 4 reports the values of paired data analysis for 
ΔSVg/SVgEXP, %LV and %H at 3 and 12 months in PGD 
and PGD0 groups. A great variability was observed in both 
groups within the first year after lung transplantation, but 
there was a significant increase in ΔSVg/SVgEXP value at 
12 months in both groups (Figure 4A,B). For the functional 
mask analysis, both groups demonstrated a significant 
decrease in the mean value of %LV (Figure 4C,D) and a 
consequent significant increase in %H (Figure 4E,F). 
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Figure 5 shows CT functional masks at 3 and 12 months 
from two representative cases belonging to the two 
transplanted groups. In order to determine the relationship 
between CT parameters, ΔSVg/SVgEXP and %LV, and VEXP/
VINSP correlations were performed in PGD and PGD0 
patients (Figure 6). VEXP/VINSP from 3 to 12 months was 
inversely associated with ΔSVg/SVgEXP (r
2=0.71, P<0.0001) 
and with %LV (r2=0.61, P<0.0001).
Discussion
Nowadays, lung transplantation is a consolidated approach 
for the treatment of end-stage respiratory diseases, but still 
burdened with high rates of complications. Despite technical 
progress has diminished the early postoperative mortality, 
the incidence of PGD remains significant; such syndrome 
is associated to poor early outcome as well as to impaired 
long-term survival (6,17,18). Why and how the early 
graft damage can affect the long-term outcome remains 
to be completely understood. The promising studies 
with CT scan were occasional and not conclusive (19). 
In the same manner, although considered a “gold standard”, 
PFTs are subject to some degree of variability and patient 
compliance. 
In our study, pulmonary function parameters were 
affected by the onset of PGD only at early time (3 months); 
at 12 months a decrease of the incidence of the effect of 
PGD was observed and no differences were found between 
the two transplanted groups. Furthermore, PFTs do not 
yield information about regional distribution of ventilation 
defects. Regional analysis with CT could be an attractive 
technique to interpret lung patterns after transplantation. 
In this  study,  we evaluate the applicat ion of  CT 
functional mask derived parameters to determine whether 
development of severe PGD in the perioperative period 
is associated with short and/or long-term postoperative 
evidences of pulmonary function alterations. Quantitative 
CT regional analysis, proposed in the frame of this work, 
may provide a significant advance in the interpretation of 
ventilation abnormalities after lung transplant.
We enrolled patients who underwent lung transplantation 
in our center and we considered the subjects who completed 
the 1-year follow-up. To avoid the confounding effect of 
the native lung on pulmonary function we only selected 
bilateral recipients with the aim to evaluate the effect of 
PGD on the ventilation defects as well as their distribution 
in space and in time. We categorized our population into 
two groups based on the occurrence of PGD within the 
first 72 hours after surgery. PGD grade 1 was present in 
only one patient. We decided to exclude PGD grade 1 from 
Figure 1 Description of the study cohort. PGD, primary graft dysfunction; ICU, intensive care unit. 
Patients underwent lung transplantation
(June 2013 to February 2017) =72 patients
CT scan at 3 and 12 months =38 patients
ICU =52 patients
Excluded =20 patients
• Not meeting inclusion criteria =14 single lung 
transplantation; 4 paediatric
• Declined to participate =2
Excluded =14 patients
• Not meeting inclusion criteria =4 PGD1;  
3 pneumonia; 2 ICU stay >3 months
• Declined to participate =0
• Other reasons =1 death; 1 bronchus stenosis;  
3 logistical problems
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the study for two main reasons: (I) grouping PGD1 with 
highest grade would had been misleading because, actually, 
the functional impairment is negligible; on the other hand, 
(II) grouping PGD1 with patients who did not experience 
pulmonary infiltrate was illogical. Only an adequate number 
of patients with PGD1 would allow a targeted analysis.
The major findings of our study are: (I) the significant 
reduction of the ΔSVg/SVgEXP in PGD and PGD0 patients 
compared to healthy (8); (II) the significant higher 
prevalence of low ventilation pattern in PGD and PGD0 
groups at 3-month follow-up; (III) the negligible differences 
in ΔSVg/SVgEXP and %LV among transplanted groups at 
3 months, and (IV) the significant higher correlation 
between the percentage of ΔSVg/SVgEXP and low ventilation 
and the VEXP/VINSP in both transplanted groups at 3 and 
12-month follow-up.
We measured ΔSVg/SVgEXP of the whole lung in order 
to quantify in a single parameter the degree of lung 
Table 1 Donor and recipient characteristics
Variables PGD Group (n=13) PGD0 Group (n=25) P
Recipient
Age (years), mean [SD] 38 [12] 42 [14] 0.956
Male sex, n [%] 5 [38] 10 [40] n.s
Positive CMV status, n [%] 9 [69] 16 [64] n.s
Weight (kg), mean [SD] 54 [11] 55 [8] 0.797
Height (m), mean [SD] 1.63 [0.1] 1.65 [0.1] 0.444
Disease, n [%]
Cystic fibrosis 9 [69] 15 [60] n.s
Pulmonary fibrosis 3 [23] 4 [16] n.s
COPD 1 [8] 4 [16] n.s
GVHD – 2 [8]
Donor
Age (years), mean [SD] 47 [7] 47 [15] 0.221
Male sex, n [%] 7 [54] 13 [52] n.s
History of smoking, n [%] 7 [54] 11 [44] n.s
Positive CMV status, n [%] 11 [80] 15 [60] n.s
Weight (kg), mean [SD] 70 [15] 74 [14] 0.279
Height (m), mean [SD] 1.70 [0.5] 1.70 [0.1] 0.546
OTO score, mean [SD] 4 [2] 3 [1] 0.683
Transplantation
Cold ischemia time, minutes, median [IQR] 898 [698–978] 1,171 [837–1,416] 0.805
Warm ischemic time, minutes, median [IQR] 206 [160–188] 156 [138–175] 0.047
ECMO pre 3 [23] 3 [12] n.s
ECMO intra 9 [69] 9 [36] n.s
ECMO post 3 [23] 3 [12] n.s
PGD Group, patients with grade 2 and/or 3 primary graft dysfunction; PGD0 Group, patients without diagnosis of PGD; CMV, 
cytomegalovirus; COPD, chronic obstructive pulmonary disease; GVHD, graft versus host disease; ECMO, extracorporeal membranous 
oxygenation; IQR, interquartile range; n.s, not significant.
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Figure 2 Box plots demonstrating distribution of ΔSVg/SVgEXP at 3 
and 12 months post-transplant in patients with PGD, and PGD0. 
Healthy values derived from the results of our previous study (8). *, 
P<0.05; ***, P<0.001. PGD, primary graft dysfunction. 
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emptying (numerator) and expiratory lung hyperinflation/
air trapping (denominator), providing a significant tool in 
the interpretation of ventilation abnormalities after lung 
transplantation. Our results demonstrate a marked decrease 
in ΔSVg/SVgEXP in all subjects, both at 3 and 12 months after 
lung transplantation, indicating a high degree of ventilation 
defects and/or expiratory lung hyperinflation affecting the 
normal distribution of lung ventilation even in patients with 
ideal post-transplantation course. In order to better identify 
the pattern of ventilation defects in the post-transplantation 
period, we introduced a novel CT-based methodology 
providing detailed information which could be the basis for 
future targeted interventions. Despite of PGD grading we 
found in all the subjects high percentages of low ventilation 
areas while air trapping or consolidation areas were 
negligible; once this clinical frame will be confirmed with 
larger studies, interventions such as non-invasive ventilation 
Figure 3 Box plots demonstrating distribution of percentages of lung volume denoted as %LV, %C, %AT and %H at 3 and 12 months 
post-transplant in patients with PGD and PGD0. PGD, primary graft dysfunction. *, P<0.05; **, P<0.01. PGD, primary graft dysfunction; 
LV, low ventilation; AT, air trapping; H, healthy parenchyma.
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could be considered to counterbalance the persisting low 
ventilation pattern. 
A further evidence that the decrease of ΔSVg/SVgEXP 
in transplanted patients is due more to ventilation defects 
rather than to air trapping and/or consolidation is provided 
by the results of Figure 6, showing that a significant, linear 
correlation between ΔSVg/SVgEXP and both the extent of 
low ventilation patterns and the decline of the ratio of lung 
Figure 4 Line plots of ΔSVg/SVgEXP (A,B), %LV (C,D) and %H (E,F) obtained at 3 and 12 months post lung transplant in PGD (right 
panels) and PGD0 (left panels) group. *, P<0.05; **, P<0.01. PGD, primary graft dysfunction; LV, low ventilation; AT, air trapping; H, 
healthy parenchyma.
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expiratory to inspiratory volumes (VEXP/VINSP) in the first 
year after lung transplantation.
Our results, therefore, suggest that when multi-volumetric 
CT scans are not available, in addition to spirometric 
indices, the measurement of static lung volumes might be 
useful to identify and differentiate particular physiological 
phenotypes and predict survival in patients with chronic lung 
allograft dysfunction as recently reported (20). 
The negligible differences in ΔSVg/SVgEXP and %LV 
among transplanted groups at short and mid-term suggests 
Figure 5 CT functional masks at 3 and 12 months from lung transplant of two representative PGD and PGD0 patients are shown at five 
equally-spaced lung levels from aortic arch (I-AA) to top diaphragm (VI-TD). Each pixel of the maps was classified as LV (green), C (blue), 
AT (red) and H (black). PGD, primary graft dysfunction; LV, low ventilation; AT, air trapping; H, healthy parenchyma.
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Figure 6 Correlation analysis are presented for the relative change in (A) ΔSVg/SVgEXP and (B) %LV to the relative change in VEXP/VINSP 
from 12 to 3 months in patients with PGD (gray circles) and PGD0 (dark gray circles). PGD, primary graft dysfunction; LV, low ventilation.
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that a number of confounding factors could play a role in 
ventilation defects. 
Our study has limitations that should be considered 
when interpreting the results. First, our study was a pilot 
prospective cohort study with a limited sample size. 
Furthermore, longer follow-up is necessary to study the 
chronic lung allograft dysfunction onset and identify the 
correlation with the PGD syndrome under the view of CT 
volume analysis. 
Conclusions
In summary, we demonstrate that quantification of 
ventilation defects by CT functional mask can offer 
insight into the correlation between PGD and pulmonary 
function after lung transplantation at short and mid-term. 
Irrespective of whether or not the occurrence of PGD, our 
results suggest the importance of careful and integrated 
functional studies as a base to a tailored respiratory 
physiotherapy aimed at contrasting the persistence of low 
ventilation areas in the lung after transplantation. Further 
multi-centric studies using a larger sample size are essential 
to investigate the usefulness of this novel methodology 
in monitoring and quantifying the distribution of lung 
abnormalities in transplanted lungs.
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